title: Complete remission of Waldenström's associated generalized crystal-storing histiocytosis of IgM lambda subtype with bortezomib-based combination chemotherapy.
authors.affiliation: a Faculty of Medicine, Nursing & Health Sciences, Monash University , Melbourne , Australia.
authors.forename: Samantha M
authors.initials: SM
authors.lastname: Baird
authors.affiliation: b Department of Haematology , Cabrini Health , Melbourne , Australia.
authors.forename: Melita K
authors.initials: MK
authors.lastname: Kenealy
authors.affiliation: c Department of Allergy , Immunology and Respiratory Medicine, Alfred Hospital , Australia.
authors.forename: Ryan
authors.initials: R
authors.lastname: Hoy
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D000069286:Bortezomib / Q000008:administration & dosage; D005260:Female; D015614:Histiocytosis / Q000150:complications* / Q000175:diagnosis* / Q000188:drug therapy; D006801:Humans; D007075:Immunoglobulin M / Q000097:blood*; D007146:Immunoglobulin lambda-Chains / Q000097:blood*; D016130:Immunophenotyping; D008875:Middle Aged; D049268:Positron-Emission Tomography; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D008258:Waldenstrom Macroglobulinemia / Q000150:complications* / Q000175:diagnosis
chemical_list: D007075:Immunoglobulin M; D007146:Immunoglobulin lambda-Chains; D000069286:Bortezomib